EVALUATION OF THE DISEASE -SPECIFIC ITEMS ON THE EORTC IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH LENVATINIB OR SORAFENIB

Hudgens, S; Copher, R; Meier, G

VALUE IN HEALTH, 2018; 21 (): S37